Dulaglutide (brand name Trulicity) is a long-acting GLP-1 receptor agonist approved by the FDA in 2014 for adults with type 2 diabetes, and later for cardiovascular risk reduction in people with established or high cardiovascular risk
According to NHS guidance, influenza is an acute viral respiratory infection characterised by sudden onset of fever (typically above 38C), dry cough, sore throat, myalgia, headache, and profound fatigue
Considering that this group of medications significantly reduces lean muscle mass, which may be particularly risky in elderly patients, those who do not lose weight or rather gain weight while using GLP1 RAs, may not be suitable to continue using these medications [20]
Mast cells are closely apposed to nerves in the human gastrointestinal mucosa
If youre worried about side effects, your doctor can support you or help you find a different treatment for obesity or weight gain that fits your goals for weight loss and weight management
Alternatively, for mothers, number of children and length of lactation are associated with a decreased risk of endometriosis (Missmer 2004)
